From Medscape Rheumatology

Coverage from the

American College of Rheumatology (ACR) 2017 Annual Meeting

November 03 - 08, 2017; San Diego, CA

November 03 - 08, 2017 San Diego, CA

Meeting Highlights At A Glance

  • Top News From ACR 2017: Slideshow Top News From ACR 2017: Slideshow A highly anticipated trial probing the benefit of stopping methotrexate for 2 weeks after flu vaccination to boost immune response in RA patients is among the meeting highlights.

Conference News

Popular News From ACR 2016

  • PRECISION: Differences Emerge Between RA and OA Patients PRECISION: Differences Emerge Between RA and OA Patients Patients with rheumatoid arthritis (RA) and osteoarthritis (OA) respond differently to NSAIDs and COX-2 inhibitors, according to a subanalysis of data from the PRECISION trial.
  • Genetic Signatures Predict Response to Treatment for RA Genetic Signatures Predict Response to Treatment for RA The identification of three genetic signatures that predict how patients with rheumatoid arthritis will respond to therapy holds promise for personalized medicine, but replication studies are needed.
  • New Guidelines Focus on Postop Infection, Not Flares New Guidelines Focus on Postop Infection, Not Flares The guidelines address the use of antirheumatic medication for patients with inflammatory arthritis who undergo total hip or knee arthroplasty, but some experts say risk for infection is not an issue.

Medscape Rheumatology©  WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

ACR on Twitter

Previous Coverage